Need and greed in dermatology: Disease and outcome measures in dermatological healthcare planning

Dermatology

Volumn 213, Issue 4, 2006, Pages 279-283

  Dalgard, Florence ^a,c   Finlay, Andrew Y ^b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Dermatology; Healthcare planning; Illness behavior; Outcome measures

Indexed keywords

CAREGIVER; HEALTH CARE MANAGEMENT; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; ILLNESS BEHAVIOR; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW;

EID: 33751541682     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096190     Document Type: Review

References (38)

1. Pencheon D: Oxford Handbook of Public Health. Oxford, Oxford University Press, 2001.
2. Chren MM, Weinstock MA: Conceptual issues in measuring the burden of skin diseases. J Invest Dermatol Symp Proc 2004;9:97-100.
3. Qureshi AA, Freedberg I, Goldsmith L, Moshell A: Report on 'Burden of Skin Disease' workshop. NIAMS, September 2002. J Invest Dermatol Symp Proc 2004;9:111-119.
4. Finlay AY: Dowling Oration 2000. Dermatology patients: what do they really need? Clin Exp Dermatol 2000;25:444-450.
5. Oppenheimer GM: Paradigm lost: race, ethnicity, and the search for a new population taxonomy. Am J Public Health 2001;91:1049-1055.
6. Murray C, Lopez A: The Global Burden of Disease. Geneva, World Health Organization, 1996.
7. Nordenfelt L, Twaddle A: Disease, Illness and Sickness: Three Central Concepts in the Theory of Health. Linköping, Linköping University, 1994.
8. Hofmann B: On the triad disease, illness and sickness. J Med Philos 2002;27:651-673.
9. Wikman A, Marklund S, Alexanderson K: Illness, disease, and sickness absence: an empirical test of differences between concepts of ill health. J Epidemiol Community Health 2005;59:450-454.
10. Last JM: A Dictionary of Epidemiology. New York, Oxford University Press, 1995.
11. Hutchinson A: Health Outcome Measures in Primary and Out-Patient Care. Amsterdam, Harwood Academic Publishers, 1996.
12. Fredriksson T, Pettersson U: Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-244.
13. Schmitt J, Wozel G: The Psoriasis Area and Severity Index is the adequate criterion to define severity in chronic plaque-type psoriasis. Dermatology 2005;210:194-199.
14. Dalgard F, Svensson A, Holm JO, Sundby J: Self-reported skin complaints: Validation of a questionnaire for population surveys. Br J Dermatol 2003;149:794-800.
15. Fleischer AB Jr, Rapp SR, Reboussin DM, Vanarthos JC, Feldman SR: Patient measurement of psoriasis disease severity with a structured instrument. J Invest Dermatol 1994;102:967-969.
16. Charman CR, Venn AJ, Williams HC: The patient-oriented eczema measure: Development and initial validation of a new tool for measuring atopic eczema severity from the patients' perspective. Arch Dermatol 2004;140:1513-1519.
17. Ware JE Jr, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
18. Finlay AY, Khan GK: Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol 1994;19:210-216.
19. Lewis V, Finlay AY: 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc 2004;9:169-180.
20. Hamm H, et al: Primary focal hyperhidrosis: disease characteristics and functional impairment. Dermatology 2006;212:343-353.
21. Schafer T: Epidemiology of psoriasis. Epidemiology 2006;212:327-337.
22. Cotterill JA, Finlay AY: General aspects of treatment; in Burns T, Breathnach S, Cox N, Griffiths C (eds): Rook's Textbook of Dermatology. Oxford, Blackwell Science, 2004.
23. Lewis VJ, Finlay AY: Two decades experience of the Psoriasis Disability Index. Dermatology 2005;210:261-268.
24. Nord E: Cost-Value Analysis in Health Care. Cambridge, Cambridge University Press, 1999.
25. Murray CJ: Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull WHO 1994;72:429-445.
26. Detels R, McEwen J, Beaglehole R, Tanaka H (eds): Oxford Textbook of Public Health, ed 4. Oxford, Oxford University Press, 2002.
27. Davey B, Popay J: Dilemmas in Health Care. Buckingham, Open University Press, 1993.
28. Ballas CA, Staab JP: Medically unexplained physical symptoms: toward an alternative paradigm for diagnosis and treatment. CNS Spectrums 2003;8:20-26.
29. Kroenke K: Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res 2003;12:34-43.
30. Malterud K: Symptoms as a source of medical knowledge: understanding medically unexplained disorders in women. Fam Med 2000;32:603-611.
31. Nimnuan C, Hotopf M, Wessely S: Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51:361-367.
32. Continuous Quality Development: A Proposed National Policy. Copenhagen, WHO Regional Office for Europe, 1993.
33. Murray CJ, Lopez AD: Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997;349:1436-1442.
34. Wulff H: Medisinsk Filosofi. København, Munksgaard, 1999.
35. Foucault M: Naissance de la clinique. Paris, Presses Universitaires de France, 1993.
36. Stewart M: Patient-Centered Medicine. Thousand Oaks, Sage, 1995.
37. Higginson IJ, Carr AJ: Measuring quality of life: using quality of life measures in the clinical setting. BMJ 2001;322:1297-1300.
38. Herzlinger R: Consumer-Driven Health Care. San Fransisco, Jossey-Bass, 2004.